Drug major Cipla has signed an agreement with its Iranian distributor for setting up a manufacturing unit in that country.
Total contribution from the Indian company over the next three years will include machinery, equipment, technical know-how and is expected to be around Rs.225 crore for a 75 per cent stake, it added.
This is a Premium article available exclusively to our subscribers. To read 250+ such premium articles every
month
You have exhausted your free article limit.
Please support quality journalism.
You have exhausted your free article limit.
Please support quality journalism.
The Hindu operates by its editorial values to provide you quality journalism.
You have read {{data.cm.views}} out of {{data.cm.maxViews}} free articles.
This is your last free article.